medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2017, Number 07

<< Back Next >>

Ginecol Obstet Mex 2017; 85 (07)

Pelvic inflammatory disease: retrospective analysis

Álvarez-Pabón Y, Sepúlveda-Agudelo J, Díaz-Martínez LA

Language: Spanish
References: 16
Page: 433-441
PDF size: 242.15 Kb.


ABSTRACT


Objetive: to describe the socio-demographic and clinical variables related to pelvic inflammatory disease cases of patients treated in the Hospital Universitario de Santander, Bucaramanga, Colombia and explore the relationship of these variables with the need for surgery.
Materials and Methods: retrospective study and analysis of medical records of patients treated between 2013 and 2014 in the “Hospital Universitario de Santander”. Data analysis was performed with STATA 12.1. Evaluation between the need for surgery and other variables using the χ2 test or the Mann-Whitney U test.
Results: 212 patients were included: 136 (64.2%) hospitalized, 35 (25.7%) required surgical intervention. For the hospitalized patients, the main regimen was clindamycin and gentamicin (55 de 136: 41.4%); the patients with ambulatory treatment received: metronidazole and doxycycline (21 de 76: 27.6%). The variables significantly associated with the need for surgery were: ultrasound findings, the diagnostic value of white blood cells and of PCR and active comorbidities.
Conclusion: pelvic inflammatory disease should be considered a differential diagnosis in any reproductive age female patient with abdominal pain; basic paraclinical parameters are a useful approach to determine the need for surgery in patients who present an acute picture.


REFERENCES

  1. Baquedano-Mainar L, Lamarca-Ballestero M, Puig-Ferrer F, Ruiz-Conde MA. Enfermedad inflamatoria pélvica: un reto en el diagnóstico y tratamiento precoz. Rev Chil Obs Ginecol 2014;79(2):115-20.

  2. Gaitán-Duarte HG, Rodríguez-Hernández AE, Grillo-Ardila CF, Páez-Canro CZ, Reyes-Sánchez JM, Muller EA, et al. Guía de Práctica Clínica para el abordaje sindrómico del diagnóstico y tratamiento de los pacientes con infecciones de transmisión sexual y otras infecciones del tracto genital. Bogotá: Ministerio de Salud y protección social. Colciencias 2013:98-106.

  3. Rodríguez-Núñez AC, Molina-Pérez CR, Pérez Pérez BC. Morbimortalidad por infección Intraabdominal de origen ginecológico. Rev Cuba Obstet y Ginecol 2006;32(2):1561-62

  4. Hernández-Durán D, Diaz- Mitjans O. Enfermedad inflamatoria pélvica. Rev Cuba Obstet y Ginecol 2010;36(4):613-31.

  5. Workowski K, Berman S. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2015; 64(3):78-84.

  6. Paniagua-Salas AM, Santana-Valenzuela CA, Contreras SM, Jiménez M, Germán-Severino AS, Cruz M. Enfermedad pélvica inflamatoria en mujeres atendidas en la clínica rural Arroyo Toro. Rev Med Dom 2010;71(1):139-41.

  7. De la Cruz GP, Bautista M. Estudio clínico-epidemiológico de la enfermedad inflamatoria pélvica aguda. Hospital Nacional Arzobispo Loayza. Rev Per Ginecol Obs 2005;51(1):126-31.

  8. French CE, Hughes G, Nicholson A, Yung M, Ross JD, Williams T, et al. Estimation of the rate of pelvic inflammatory disease diagnoses: trends in England, 2000-2008. Sex Transm Dis 2011;38(3):158-62.

  9. Reckart ML, Gilbert M, Meza R, Kim PH, Chang M, Money DM, et al. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. JID 2012; 207:30-38.

  10. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision [en línea]. Dirección URL: http://apps.who.int/ classifications/icd10/browse/2010/en (Consulta: enero 2016)

  11. Ross J, Judlin P, Jensen J. 2012 European guide line for the management of pelvic inflammatory disease. Int J STD AIDS 2014;25(1):1-7.

  12. Abehsera-Davó D, Panal-Cusati M, Sánchez-Pastor M, Herrera de la Muela M, de Santiago-García FJ. Resultados tras un protocolo de actuación en pacientes con diagnóstico de enfermedad inflamatoria pélvica grave. Ginecol Obstet Mex 2013;81: 304-9.

  13. Kim HY, Yang JI, Moon C. Comparison of severe pelvic inflammatory disease, pyosalpinx and tubo-ovarian abscess. J Obstet Gynaecol Res 2015;41(5):742-6.

  14. Xholli A, Cannoletta M, Cagnacci A. Season al trend of acute pelvic inflammatory disease. Arch Gynecol Obs 2014;289: 1017-22.

  15. Terao M, Koga K, Fujimoto A, Wada-Hiraike , Yosuga Y, Yano T, et al. Factors that predict poor clinical course among patients hospitalized with Pelvic inflammatory disease. J Obs Gynaecol Res 2014;40(2):495-500.

  16. Wiske CP, Palisoul M, Tapé C, Baird J MA. Physician Specialty Influences Care of Pelvic Inflammatory Disease. J Womens Health 2016;25(7):723-8.




2020     |     www.medigraphic.com